Molecular Medicine Division, Bose Institute, P-1/12, C. I. T. Scheme VII M, Kolkata, 700054, India.
Glycoconj J. 2011 Jan;28(1):11-9. doi: 10.1007/s10719-010-9317-y. Epub 2010 Dec 22.
A convenient synthetic strategy of the common acidic pentasaccharide repeating unit corresponding to the O-antigen of enterotoxigenic E. coli O168 and Shigella dysenteriae type 4 has been successfully developed. A stereoselective [2 + 3] block glycosylation method has been exploited to get the target pentasaccharide derivative. Most of the synthetic intermediates were solid and prepared in high yields from commercially available reducing sugars following a series of protection-deprotection reactions. A α-D-mannose moiety has been used as the source of α-D-glucosamine moiety. A late-stage TEMPO mediated selective oxidation reaction finally resulted in the pentasaccharide containing a glucuronic acid unit.
一种方便的合成策略,用于合成与肠毒性大肠杆菌 O168 和志贺氏痢疾杆菌 4 型 O 抗原相对应的常见酸性五糖重复单元,已成功开发。利用立体选择性 [2 + 3] 块糖苷化方法获得目标五糖衍生物。大多数合成中间体均为固体,并且可以通过一系列保护-脱保护反应从商业上可获得的还原糖中以高产率制备。使用 α-D-甘露糖部分作为 α-D-葡糖胺部分的来源。在后期阶段,TEMPO 介导的选择性氧化反应最终导致含有葡萄糖醛酸单元的五糖。